版本:
中国

BRIEF-Glenmark to initiate clinical study for GBR 1342

May 15 Glenmark Pharmaceuticals Ltd

* Glenmark pharmaceuticals to initiate clinical study for gbr 1342, second investigational new drug from immuno-oncology portfolio Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐